bpc-157 chemical structure BPC-157 Mechanism of Action: VEGF,

10.1097/00003086-199404000-00046 24 DamienC

Fat oxidation without blood sugar disruption

Patients who undergo BPC-157 therapy often experience shorter recovery times, reduced discomfort, and enhanced resilience against long-term damage

nNOS: a neuronal cytosolic variant commonly localized to post-synaptic densities, and generally accepted to be the most involved enzyme in physiological co-transmission iNOS: a cytosolic variant expressed in a range of cells including transmission-relevant astrocytes and microglia, from which it likely plays an indirect co-transmission role eNOS: a primarily endothelial membrane-localized variant that is likely the least relevant for co-transmission NOS synthesizes NO by deiminating L-arginine into L-citrulline, short circuiting the urea cyclewhen it is present